TransMedics Group DEF 14A: Executive Compensation Details
Ticker: TMDX · Form: DEF 14A · Filed: Apr 10, 2025 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | DEF 14A |
| Filed Date | Apr 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards, sec-filing
TL;DR
TransMedics Group DEF 14A out: Executive pay & equity awards for 2020-2024 detailed. Focus on PEO vs Non-PEO compensation.
AI Summary
TransMedics Group, Inc. filed a DEF 14A on April 10, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and equity awards granted to its principal executive officers (PEO) and non-principal executive officers (Non-PEO) for the fiscal years 2020 through 2024. It includes information on the year-end fair value of outstanding and unvested equity awards, as well as changes in the fair value of awards.
Why It Matters
This filing provides crucial insights into how TransMedics Group compensates its top executives, which can influence employee morale, investor perception, and the company's long-term strategic decisions.
Risk Assessment
Risk Level: medium — DEF 14A filings, while routine, can reveal significant information about executive compensation and potential shareholder concerns, impacting stock valuation.
Key Numbers
- 2024-12-31 — Fiscal Year End (The reporting period for which compensation details are provided.)
- 20250410 — Filing Date (The date the DEF 14A was submitted to the SEC.)
- 2020-2024 — Fiscal Years Covered (The range of fiscal years for which executive compensation data is presented.)
Key Players & Entities
- TransMedics Group, Inc. (company) — Filer of the DEF 14A
- 0001756262 (company) — Central Index Key for TransMedics Group, Inc.
- 200 MINUTEMAN ROAD, ANDOVER, MA 01810 (address) — Business and Mail Address for TransMedics Group, Inc.
- 9785520900 (phone) — Business Phone Number for TransMedics Group, Inc.
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a proxy statement filed by a company with the SEC to solicit shareholder votes on important corporate matters, often including executive compensation, director elections, and other proposals.
Who are the 'PEO' and 'Non-PEO' members mentioned in the filing?
PEO stands for Principal Executive Officer, and Non-PEO refers to other executive officers. The filing distinguishes compensation and equity awards between these two groups.
What kind of financial data related to equity awards is detailed?
The filing details the year-end fair value of equity awards granted, outstanding, and unvested, as well as changes in the fair value of these awards over time.
What is the SIC code for TransMedics Group, Inc.?
The Standard Industrial Classification (SIC) code for TransMedics Group, Inc. is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
When is TransMedics Group's fiscal year end?
TransMedics Group's fiscal year ends on December 31st.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 10, 2025 regarding TransMedics Group, Inc. (TMDX).